Loading
CSL Limited Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest, by Ms Carolyn Hewson AO, was filed 04 Jun 2026.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€127,592
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleGordon Naylor1 buy
Carolyn Hewson AO1 buy
Since the insiders bought
- +96.9%Entry A$99.47 · Close 21 Oct 2026 A$195.85
- +102.7%Entry A$96.61 · Close 21 Oct 2026 A$195.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate CSL Limited Buy (bullish), based on 17 analysts. Average price target: A$185.10.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,408 of 26,286 companies
35.3
score / 100
Value38
Quality32
FCF yld2.4%
Earn yld-2.7%
EV/EBITDA·
ROE-16%
Gross mgn51%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
A$196.30
Analyst consensus
17 analystsBuy
A$152.56Target A$185.10(-6%)A$214.04
Income statement
RevenueA$15.7B
Gross profitA$8B51% margin
EBITDA-A$2.7B-17% margin
Net income-A$2.6B-16.3% margin
Valuation
PER (forward)29.6x
P/Book4.4x
Beta0.08
Balance sheet & cash
Market capA$94.2B
Total debtA$10.9B
Free Cash FlowA$2.2B
Debt / Equity67%
Profitability & ownership
ROE-15.8%
ROA7.3%
% insiders0.0%
% institutions38.2%
Last declaration on 27 August 2026
Declarations10 total
0@ A$220.39820.0001% mcap100.0% of flowShareASXASX:2924-03127604-3A700140
0@ A$152.79040.0001% mcap100.0% of flowShareASXASX:2924-03127599-3A700138
0@ A$153.07240.0000% mcap100.0% of flowShareASXASX:2924-03127597-3A700137
0@ A$220.81140.0000% mcap100.0% of flowShareASXASX:2924-03127594-3A700136
0@ A$220.26730.0001% mcap100.0% of flowShareASXASX:2924-03127591-3A700134
0@ A$220.5670.0000% mcap100.0% of flowShareASXASX:2924-03127588-3A700133
0@ A$219.87490.0001% mcap100.0% of flowShareASXASX:2924-03127583-3A700132
1,036 shares@ A$95.890.0001% mcap100.0% of flowShareASXISIN AU000000CSL8ASX:2924-03097500-3A694784
Canonical exit: 30 Aug 2026 (T+90)
1,100 shares@ A$98.000.0001% mcap100.0% of flowShareASXISIN AU000000CSL8ASX:2924-03094457-3A694159
Canonical exit: 24 Aug 2026 (T+90)
ShareASXISIN AU000000CSL8ASX:2924-03087920-3A692930
10 of 10 declarations
About CSL Limited
Of 10 filings at CSL Limited, an Australian health care company listed in Sydney (market capitalisation of AUD 94.2 billion), 8 are of a kind other than purchase or sale and 2 are director purchases, worth EUR 127,592 in total. No insider holds a significant share of the capital according to the record (0%).
The purchases follow one another: Gordon Naylor, a Director, bought EUR 66,425 on May 26, 2026, then Carolyn Hewson AO, also a Director, EUR 61,167 on June 1, 2026. The amounts of the two filers are of the same order. Carolyn Hewson AO appears in 2 filings, the other filers, including Alison Watkins AM, Constantine Saroukos, Cameron Bruce Price and Samantha Lewis, in one each.
Read moreShow less
All filings date from 2026 and fall in the last twelve months, with trades running from May 26, 2026 to August 21, 2026. Nine filers appear in the record. The publication delay is a median of 6 days.
